Decision to consider abortion drug mifepristone returns the issue of reproductive rights to the high court for the first time since it overturned Roe v. Wade.
The Supreme Court has ruled that mifepristone, a key abortion drug, will remain available for now under existing regulations while the litigation continues.
The three judges, who have previously restricted abortion, expressed skepticism that the U.S. acted properly when it made mifepristone more easily available.
The court’s orders came on the final day of its term, as the justices announced what additional cases they will review when the court reconvenes in the fall.